Global Potassium Channel Blocker Market Growth 2025-2031

October 2025 | 115 pages | ID: GE15821D22CAEN
LP Information

Abstracts

The global Potassium Channel Blocker market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Potassium Channel Blockers is a class of drugs that act by inhibition of potassium efflux through cell membranes.

United States market for Potassium Channel Blocker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Potassium Channel Blocker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Potassium Channel Blocker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Potassium Channel Blocker players cover Kineta, Sevion Therapeutics, Cono Genetix, KPI Therapeutics, Amgen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Potassium Channel Blocker Industry Forecast? looks at past sales and reviews total world Potassium Channel Blocker sales in 2024, providing a comprehensive analysis by region and market sector of projected Potassium Channel Blocker sales for 2025 through 2031. With Potassium Channel Blocker sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Potassium Channel Blocker industry.

This Insight Report provides a comprehensive analysis of the global Potassium Channel Blocker landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Potassium Channel Blocker portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Potassium Channel Blocker market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Potassium Channel Blocker and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Potassium Channel Blocker.

This report presents a comprehensive overview, market shares, and growth opportunities of Potassium Channel Blocker market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Clinical
• Non-clinical

Segmentation by Application:

• Clinic
• Hospital

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Kineta
• Sevion Therapeutics
• Cono Genetix
• KPI Therapeutics
• Amgen
• Agenus bio
• Bristol-Myers Squibb
• Enumeral
• F-star
• GlaxoSmithKline
• North Coast Bio
• Novartis
• Regeneron

Key Questions Addressed in this Report

What is the 10-year outlook for the global Potassium Channel Blocker market?
What factors are driving Potassium Channel Blocker market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Potassium Channel Blocker market opportunities vary by end market size?
How does Potassium Channel Blocker break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Potassium Channel Blocker Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Potassium Channel Blocker by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Potassium Channel Blocker by Country/Region, 2020, 2024 & 2031
2.2 Potassium Channel Blocker Segment by Type
  2.2.1 Clinical
  2.2.2 Non-clinical
2.3 Potassium Channel Blocker Sales by Type
  2.3.1 Global Potassium Channel Blocker Sales Market Share by Type (2020-2025)
  2.3.2 Global Potassium Channel Blocker Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Potassium Channel Blocker Sale Price by Type (2020-2025)
2.4 Potassium Channel Blocker Segment by Application
  2.4.1 Clinic
  2.4.2 Hospital
2.5 Potassium Channel Blocker Sales by Application
  2.5.1 Global Potassium Channel Blocker Sale Market Share by Application (2020-2025)
  2.5.2 Global Potassium Channel Blocker Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Potassium Channel Blocker Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Potassium Channel Blocker Breakdown Data by Company
  3.1.1 Global Potassium Channel Blocker Annual Sales by Company (2020-2025)
  3.1.2 Global Potassium Channel Blocker Sales Market Share by Company (2020-2025)
3.2 Global Potassium Channel Blocker Annual Revenue by Company (2020-2025)
  3.2.1 Global Potassium Channel Blocker Revenue by Company (2020-2025)
  3.2.2 Global Potassium Channel Blocker Revenue Market Share by Company (2020-2025)
3.3 Global Potassium Channel Blocker Sale Price by Company
3.4 Key Manufacturers Potassium Channel Blocker Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Potassium Channel Blocker Product Location Distribution
  3.4.2 Players Potassium Channel Blocker Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR POTASSIUM CHANNEL BLOCKER BY GEOGRAPHIC REGION

4.1 World Historic Potassium Channel Blocker Market Size by Geographic Region (2020-2025)
  4.1.1 Global Potassium Channel Blocker Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Potassium Channel Blocker Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Potassium Channel Blocker Market Size by Country/Region (2020-2025)
  4.2.1 Global Potassium Channel Blocker Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Potassium Channel Blocker Annual Revenue by Country/Region (2020-2025)
4.3 Americas Potassium Channel Blocker Sales Growth
4.4 APAC Potassium Channel Blocker Sales Growth
4.5 Europe Potassium Channel Blocker Sales Growth
4.6 Middle East & Africa Potassium Channel Blocker Sales Growth

5 AMERICAS

5.1 Americas Potassium Channel Blocker Sales by Country
  5.1.1 Americas Potassium Channel Blocker Sales by Country (2020-2025)
  5.1.2 Americas Potassium Channel Blocker Revenue by Country (2020-2025)
5.2 Americas Potassium Channel Blocker Sales by Type (2020-2025)
5.3 Americas Potassium Channel Blocker Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Potassium Channel Blocker Sales by Region
  6.1.1 APAC Potassium Channel Blocker Sales by Region (2020-2025)
  6.1.2 APAC Potassium Channel Blocker Revenue by Region (2020-2025)
6.2 APAC Potassium Channel Blocker Sales by Type (2020-2025)
6.3 APAC Potassium Channel Blocker Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Potassium Channel Blocker by Country
  7.1.1 Europe Potassium Channel Blocker Sales by Country (2020-2025)
  7.1.2 Europe Potassium Channel Blocker Revenue by Country (2020-2025)
7.2 Europe Potassium Channel Blocker Sales by Type (2020-2025)
7.3 Europe Potassium Channel Blocker Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Potassium Channel Blocker by Country
  8.1.1 Middle East & Africa Potassium Channel Blocker Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Potassium Channel Blocker Revenue by Country (2020-2025)
8.2 Middle East & Africa Potassium Channel Blocker Sales by Type (2020-2025)
8.3 Middle East & Africa Potassium Channel Blocker Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Potassium Channel Blocker
10.3 Manufacturing Process Analysis of Potassium Channel Blocker
10.4 Industry Chain Structure of Potassium Channel Blocker

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Potassium Channel Blocker Distributors
11.3 Potassium Channel Blocker Customer

12 WORLD FORECAST REVIEW FOR POTASSIUM CHANNEL BLOCKER BY GEOGRAPHIC REGION

12.1 Global Potassium Channel Blocker Market Size Forecast by Region
  12.1.1 Global Potassium Channel Blocker Forecast by Region (2026-2031)
  12.1.2 Global Potassium Channel Blocker Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Potassium Channel Blocker Forecast by Type (2026-2031)
12.7 Global Potassium Channel Blocker Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Kineta
  13.1.1 Kineta Company Information
  13.1.2 Kineta Potassium Channel Blocker Product Portfolios and Specifications
  13.1.3 Kineta Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Kineta Main Business Overview
  13.1.5 Kineta Latest Developments
13.2 Sevion Therapeutics
  13.2.1 Sevion Therapeutics Company Information
  13.2.2 Sevion Therapeutics Potassium Channel Blocker Product Portfolios and Specifications
  13.2.3 Sevion Therapeutics Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Sevion Therapeutics Main Business Overview
  13.2.5 Sevion Therapeutics Latest Developments
13.3 Cono Genetix
  13.3.1 Cono Genetix Company Information
  13.3.2 Cono Genetix Potassium Channel Blocker Product Portfolios and Specifications
  13.3.3 Cono Genetix Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Cono Genetix Main Business Overview
  13.3.5 Cono Genetix Latest Developments
13.4 KPI Therapeutics
  13.4.1 KPI Therapeutics Company Information
  13.4.2 KPI Therapeutics Potassium Channel Blocker Product Portfolios and Specifications
  13.4.3 KPI Therapeutics Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 KPI Therapeutics Main Business Overview
  13.4.5 KPI Therapeutics Latest Developments
13.5 Amgen
  13.5.1 Amgen Company Information
  13.5.2 Amgen Potassium Channel Blocker Product Portfolios and Specifications
  13.5.3 Amgen Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Amgen Main Business Overview
  13.5.5 Amgen Latest Developments
13.6 Agenus bio
  13.6.1 Agenus bio Company Information
  13.6.2 Agenus bio Potassium Channel Blocker Product Portfolios and Specifications
  13.6.3 Agenus bio Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Agenus bio Main Business Overview
  13.6.5 Agenus bio Latest Developments
13.7 Bristol-Myers Squibb
  13.7.1 Bristol-Myers Squibb Company Information
  13.7.2 Bristol-Myers Squibb Potassium Channel Blocker Product Portfolios and Specifications
  13.7.3 Bristol-Myers Squibb Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Bristol-Myers Squibb Main Business Overview
  13.7.5 Bristol-Myers Squibb Latest Developments
13.8 Enumeral
  13.8.1 Enumeral Company Information
  13.8.2 Enumeral Potassium Channel Blocker Product Portfolios and Specifications
  13.8.3 Enumeral Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Enumeral Main Business Overview
  13.8.5 Enumeral Latest Developments
13.9 F-star
  13.9.1 F-star Company Information
  13.9.2 F-star Potassium Channel Blocker Product Portfolios and Specifications
  13.9.3 F-star Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 F-star Main Business Overview
  13.9.5 F-star Latest Developments
13.10 GlaxoSmithKline
  13.10.1 GlaxoSmithKline Company Information
  13.10.2 GlaxoSmithKline Potassium Channel Blocker Product Portfolios and Specifications
  13.10.3 GlaxoSmithKline Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 GlaxoSmithKline Main Business Overview
  13.10.5 GlaxoSmithKline Latest Developments
13.11 North Coast Bio
  13.11.1 North Coast Bio Company Information
  13.11.2 North Coast Bio Potassium Channel Blocker Product Portfolios and Specifications
  13.11.3 North Coast Bio Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 North Coast Bio Main Business Overview
  13.11.5 North Coast Bio Latest Developments
13.12 Novartis
  13.12.1 Novartis Company Information
  13.12.2 Novartis Potassium Channel Blocker Product Portfolios and Specifications
  13.12.3 Novartis Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Novartis Main Business Overview
  13.12.5 Novartis Latest Developments
13.13 Regeneron
  13.13.1 Regeneron Company Information
  13.13.2 Regeneron Potassium Channel Blocker Product Portfolios and Specifications
  13.13.3 Regeneron Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Regeneron Main Business Overview
  13.13.5 Regeneron Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Potassium Channel Blocker Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Potassium Channel Blocker Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Clinical
Table 4. Major Players of Non-clinical
Table 5. Global Potassium Channel Blocker Sales by Type (2020-2025) & (Units)
Table 6. Global Potassium Channel Blocker Sales Market Share by Type (2020-2025)
Table 7. Global Potassium Channel Blocker Revenue by Type (2020-2025) & ($ million)
Table 8. Global Potassium Channel Blocker Revenue Market Share by Type (2020-2025)
Table 9. Global Potassium Channel Blocker Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Potassium Channel Blocker Sale by Application (2020-2025) & (Units)
Table 11. Global Potassium Channel Blocker Sale Market Share by Application (2020-2025)
Table 12. Global Potassium Channel Blocker Revenue by Application (2020-2025) & ($ million)
Table 13. Global Potassium Channel Blocker Revenue Market Share by Application (2020-2025)
Table 14. Global Potassium Channel Blocker Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Potassium Channel Blocker Sales by Company (2020-2025) & (Units)
Table 16. Global Potassium Channel Blocker Sales Market Share by Company (2020-2025)
Table 17. Global Potassium Channel Blocker Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Potassium Channel Blocker Revenue Market Share by Company (2020-2025)
Table 19. Global Potassium Channel Blocker Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Potassium Channel Blocker Producing Area Distribution and Sales Area
Table 21. Players Potassium Channel Blocker Products Offered
Table 22. Potassium Channel Blocker Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Potassium Channel Blocker Sales by Geographic Region (2020-2025) & (Units)
Table 26. Global Potassium Channel Blocker Sales Market Share Geographic Region (2020-2025)
Table 27. Global Potassium Channel Blocker Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Potassium Channel Blocker Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Potassium Channel Blocker Sales by Country/Region (2020-2025) & (Units)
Table 30. Global Potassium Channel Blocker Sales Market Share by Country/Region (2020-2025)
Table 31. Global Potassium Channel Blocker Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Potassium Channel Blocker Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Potassium Channel Blocker Sales by Country (2020-2025) & (Units)
Table 34. Americas Potassium Channel Blocker Sales Market Share by Country (2020-2025)
Table 35. Americas Potassium Channel Blocker Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Potassium Channel Blocker Sales by Type (2020-2025) & (Units)
Table 37. Americas Potassium Channel Blocker Sales by Application (2020-2025) & (Units)
Table 38. APAC Potassium Channel Blocker Sales by Region (2020-2025) & (Units)
Table 39. APAC Potassium Channel Blocker Sales Market Share by Region (2020-2025)
Table 40. APAC Potassium Channel Blocker Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Potassium Channel Blocker Sales by Type (2020-2025) & (Units)
Table 42. APAC Potassium Channel Blocker Sales by Application (2020-2025) & (Units)
Table 43. Europe Potassium Channel Blocker Sales by Country (2020-2025) & (Units)
Table 44. Europe Potassium Channel Blocker Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Potassium Channel Blocker Sales by Type (2020-2025) & (Units)
Table 46. Europe Potassium Channel Blocker Sales by Application (2020-2025) & (Units)
Table 47. Middle East & Africa Potassium Channel Blocker Sales by Country (2020-2025) & (Units)
Table 48. Middle East & Africa Potassium Channel Blocker Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Potassium Channel Blocker Sales by Type (2020-2025) & (Units)
Table 50. Middle East & Africa Potassium Channel Blocker Sales by Application (2020-2025) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Potassium Channel Blocker
Table 52. Key Market Challenges & Risks of Potassium Channel Blocker
Table 53. Key Industry Trends of Potassium Channel Blocker
Table 54. Potassium Channel Blocker Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Potassium Channel Blocker Distributors List
Table 57. Potassium Channel Blocker Customer List
Table 58. Global Potassium Channel Blocker Sales Forecast by Region (2026-2031) & (Units)
Table 59. Global Potassium Channel Blocker Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Potassium Channel Blocker Sales Forecast by Country (2026-2031) & (Units)
Table 61. Americas Potassium Channel Blocker Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Potassium Channel Blocker Sales Forecast by Region (2026-2031) & (Units)
Table 63. APAC Potassium Channel Blocker Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Potassium Channel Blocker Sales Forecast by Country (2026-2031) & (Units)
Table 65. Europe Potassium Channel Blocker Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Potassium Channel Blocker Sales Forecast by Country (2026-2031) & (Units)
Table 67. Middle East & Africa Potassium Channel Blocker Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Potassium Channel Blocker Sales Forecast by Type (2026-2031) & (Units)
Table 69. Global Potassium Channel Blocker Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Potassium Channel Blocker Sales Forecast by Application (2026-2031) & (Units)
Table 71. Global Potassium Channel Blocker Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Kineta Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 73. Kineta Potassium Channel Blocker Product Portfolios and Specifications
Table 74. Kineta Potassium Channel Blocker Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Kineta Main Business
Table 76. Kineta Latest Developments
Table 77. Sevion Therapeutics Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 78. Sevion Therapeutics Potassium Channel Blocker Product Portfolios and Specifications
Table 79. Sevion Therapeutics Potassium Channel Blocker Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Sevion Therapeutics Main Business
Table 81. Sevion Therapeutics Latest Developments
Table 82. Cono Genetix Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 83. Cono Genetix Potassium Channel Blocker Product Portfolios and Specifications
Table 84. Cono Genetix Potassium Channel Blocker Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Cono Genetix Main Business
Table 86. Cono Genetix Latest Developments
Table 87. KPI Therapeutics Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 88. KPI Therapeutics Potassium Channel Blocker Product Portfolios and Specifications
Table 89. KPI Therapeutics Potassium Channel Blocker Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. KPI Therapeutics Main Business
Table 91. KPI Therapeutics Latest Developments
Table 92. Amgen Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 93. Amgen Potassium Channel Blocker Product Portfolios and Specifications
Table 94. Amgen Potassium Channel Blocker Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Amgen Main Business
Table 96. Amgen Latest Developments
Table 97. Agenus bio Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 98. Agenus bio Potassium Channel Blocker Product Portfolios and Specifications
Table 99. Agenus bio Potassium Channel Blocker Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Agenus bio Main Business
Table 101. Agenus bio Latest Developments
Table 102. Bristol-Myers Squibb Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 103. Bristol-Myers Squibb Potassium Channel Blocker Product Portfolios and Specifications
Table 104. Bristol-Myers Squibb Potassium Channel Blocker Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Bristol-Myers Squibb Main Business
Table 106. Bristol-Myers Squibb Latest Developments
Table 107. Enumeral Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 108. Enumeral Potassium Channel Blocker Product Portfolios and Specifications
Table 109. Enumeral Potassium Channel Blocker Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Enumeral Main Business
Table 111. Enumeral Latest Developments
Table 112. F-star Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 113. F-star Potassium Channel Blocker Product Portfolios and Specifications
Table 114. F-star Potassium Channel Blocker Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. F-star Main Business
Table 116. F-star Latest Developments
Table 117. GlaxoSmithKline Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 118. GlaxoSmithKline Potassium Channel Blocker Product Portfolios and Specifications
Table 119. GlaxoSmithKline Potassium Channel Blocker Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. GlaxoSmithKline Main Business
Table 121. GlaxoSmithKline Latest Developments
Table 122. North Coast Bio Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 123. North Coast Bio Potassium Channel Blocker Product Portfolios and Specifications
Table 124. North Coast Bio Potassium Channel Blocker Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. North Coast Bio Main Business
Table 126. North Coast Bio Latest Developments
Table 127. Novartis Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 128. Novartis Potassium Channel Blocker Product Portfolios and Specifications
Table 129. Novartis Potassium Channel Blocker Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Novartis Main Business
Table 131. Novartis Latest Developments
Table 132. Regeneron Basic Information, Potassium Channel Blocker Manufacturing Base, Sales Area and Its Competitors
Table 133. Regeneron Potassium Channel Blocker Product Portfolios and Specifications
Table 134. Regeneron Potassium Channel Blocker Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Regeneron Main Business
Table 136. Regeneron Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Potassium Channel Blocker
Figure 2. Potassium Channel Blocker Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Potassium Channel Blocker Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Potassium Channel Blocker Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Potassium Channel Blocker Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Potassium Channel Blocker Sales Market Share by Country/Region (2024)
Figure 10. Potassium Channel Blocker Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Clinical
Figure 12. Product Picture of Non-clinical
Figure 13. Global Potassium Channel Blocker Sales Market Share by Type in 2025
Figure 14. Global Potassium Channel Blocker Revenue Market Share by Type (2020-2025)
Figure 15. Potassium Channel Blocker Consumed in Clinic
Figure 16. Global Potassium Channel Blocker Market: Clinic (2020-2025) & (Units)
Figure 17. Potassium Channel Blocker Consumed in Hospital
Figure 18. Global Potassium Channel Blocker Market: Hospital (2020-2025) & (Units)
Figure 19. Global Potassium Channel Blocker Sale Market Share by Application (2024)
Figure 20. Global Potassium Channel Blocker Revenue Market Share by Application in 2025
Figure 21. Potassium Channel Blocker Sales by Company in 2025 (Units)
Figure 22. Global Potassium Channel Blocker Sales Market Share by Company in 2025
Figure 23. Potassium Channel Blocker Revenue by Company in 2025 ($ millions)
Figure 24. Global Potassium Channel Blocker Revenue Market Share by Company in 2025
Figure 25. Global Potassium Channel Blocker Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Potassium Channel Blocker Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Potassium Channel Blocker Sales 2020-2025 (Units)
Figure 28. Americas Potassium Channel Blocker Revenue 2020-2025 ($ millions)
Figure 29. APAC Potassium Channel Blocker Sales 2020-2025 (Units)
Figure 30. APAC Potassium Channel Blocker Revenue 2020-2025 ($ millions)
Figure 31. Europe Potassium Channel Blocker Sales 2020-2025 (Units)
Figure 32. Europe Potassium Channel Blocker Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Potassium Channel Blocker Sales 2020-2025 (Units)
Figure 34. Middle East & Africa Potassium Channel Blocker Revenue 2020-2025 ($ millions)
Figure 35. Americas Potassium Channel Blocker Sales Market Share by Country in 2025
Figure 36. Americas Potassium Channel Blocker Revenue Market Share by Country (2020-2025)
Figure 37. Americas Potassium Channel Blocker Sales Market Share by Type (2020-2025)
Figure 38. Americas Potassium Channel Blocker Sales Market Share by Application (2020-2025)
Figure 39. United States Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Potassium Channel Blocker Sales Market Share by Region in 2025
Figure 44. APAC Potassium Channel Blocker Revenue Market Share by Region (2020-2025)
Figure 45. APAC Potassium Channel Blocker Sales Market Share by Type (2020-2025)
Figure 46. APAC Potassium Channel Blocker Sales Market Share by Application (2020-2025)
Figure 47. China Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 51. India Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Potassium Channel Blocker Sales Market Share by Country in 2025
Figure 55. Europe Potassium Channel Blocker Revenue Market Share by Country (2020-2025)
Figure 56. Europe Potassium Channel Blocker Sales Market Share by Type (2020-2025)
Figure 57. Europe Potassium Channel Blocker Sales Market Share by Application (2020-2025)
Figure 58. Germany Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 59. France Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Potassium Channel Blocker Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Potassium Channel Blocker Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Potassium Channel Blocker Sales Market Share by Application (2020-2025)
Figure 66. Egypt Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Potassium Channel Blocker Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Potassium Channel Blocker in 2025
Figure 72. Manufacturing Process Analysis of Potassium Channel Blocker
Figure 73. Industry Chain Structure of Potassium Channel Blocker
Figure 74. Channels of Distribution
Figure 75. Global Potassium Channel Blocker Sales Market Forecast by Region (2026-2031)
Figure 76. Global Potassium Channel Blocker Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Potassium Channel Blocker Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Potassium Channel Blocker Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Potassium Channel Blocker Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Potassium Channel Blocker Revenue Market Share Forecast by Application (2026-2031)